Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| DEAD Box Protein 58 | 2 | 2017 | 250 | 1.12 | Why? |
| Zika Virus Infection | 5 | 2018 | 1920 | 0.92 | Why? |
| Antibodies, Neutralizing | 25 | 2021 | 25288 | 0.82 | Why? |
| Maternal-Fetal Exchange | 1 | 2020 | 209 | 0.77 | Why? |
| Interferon Type I | 3 | 2020 | 2789 | 0.66 | Why? |
| West Nile virus | 1 | 2018 | 206 | 0.64 | Why? |
| West Nile Fever | 1 | 2018 | 166 | 0.61 | Why? |
| Antibodies, Viral | 24 | 2021 | 51949 | 0.60 | Why? |
| Antibody-Dependent Enhancement | 2 | 2018 | 413 | 0.59 | Why? |
| Interferon-Induced Helicase, IFIH1 | 1 | 2017 | 245 | 0.58 | Why? |
| Neutralization Tests | 7 | 2021 | 6698 | 0.56 | Why? |
| Zika Virus | 4 | 2018 | 1924 | 0.49 | Why? |
| Placenta | 2 | 2020 | 1531 | 0.45 | Why? |
| Dengue Virus | 1 | 2018 | 910 | 0.44 | Why? |
| Cross Reactions | 4 | 2021 | 4374 | 0.40 | Why? |
| Virus Diseases | 2 | 2018 | 3779 | 0.40 | Why? |
| Spike Glycoprotein, Coronavirus | 22 | 2021 | 37182 | 0.35 | Why? |
| Dendritic Cells | 1 | 2017 | 1330 | 0.35 | Why? |
| Epithelial Cells | 1 | 2020 | 3508 | 0.35 | Why? |
| Immunity, Innate | 5 | 2021 | 6570 | 0.35 | Why? |
| Interferons | 1 | 2020 | 2885 | 0.35 | Why? |
| Immune Evasion | 2 | 2021 | 2081 | 0.34 | Why? |
| Adjuvants, Immunologic | 3 | 2021 | 1709 | 0.33 | Why? |
| Macrophages | 1 | 2018 | 2784 | 0.32 | Why? |
| Alum Compounds | 3 | 2021 | 210 | 0.31 | Why? |
| Infectious Disease Transmission, Vertical | 2 | 2020 | 5164 | 0.31 | Why? |
| Dengue | 1 | 2018 | 1565 | 0.30 | Why? |
| CD8-Positive T-Lymphocytes | 3 | 2021 | 5837 | 0.28 | Why? |
| Brain | 2 | 2018 | 5133 | 0.26 | Why? |
| Immunologic Memory | 3 | 2021 | 3362 | 0.26 | Why? |
| Animals | 21 | 2021 | 78931 | 0.24 | Why? |
| Stearic Acids | 1 | 2021 | 30 | 0.23 | Why? |
| Primates | 2 | 2021 | 584 | 0.23 | Why? |
| Saccharomycetales | 1 | 2021 | 118 | 0.21 | Why? |
| Uterus | 1 | 2020 | 98 | 0.21 | Why? |
| Viral Nonstructural Proteins | 1 | 2018 | 4810 | 0.20 | Why? |
| Adaptor Proteins, Signal Transducing | 2 | 2017 | 502 | 0.20 | Why? |
| Immunity, Cellular | 4 | 2021 | 3614 | 0.18 | Why? |
| Vero Cells | 5 | 2021 | 14117 | 0.18 | Why? |
| Vaccinia virus | 1 | 2021 | 346 | 0.18 | Why? |
| Heterocyclic Compounds, 3-Ring | 1 | 2021 | 275 | 0.18 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2020 | 640 | 0.18 | Why? |
| Chorionic Villi | 1 | 2018 | 73 | 0.18 | Why? |
| Antibodies, Monoclonal | 4 | 2021 | 8041 | 0.18 | Why? |
| Cells, Cultured | 2 | 2020 | 5835 | 0.17 | Why? |
| Adaptive Immunity | 2 | 2021 | 2585 | 0.17 | Why? |
| Mice, Transgenic | 3 | 2021 | 2739 | 0.17 | Why? |
| Feedback, Physiological | 1 | 2017 | 56 | 0.17 | Why? |
| Virus Assembly | 1 | 2020 | 438 | 0.17 | Why? |
| B-Lymphocytes | 3 | 2021 | 4418 | 0.17 | Why? |
| Immunogenicity, Vaccine | 3 | 2021 | 4624 | 0.17 | Why? |
| Adoptive Transfer | 1 | 2018 | 250 | 0.16 | Why? |
| Cell Line | 6 | 2021 | 12040 | 0.16 | Why? |
| Receptors, Pattern Recognition | 1 | 2017 | 128 | 0.16 | Why? |
| Immunity, Humoral | 4 | 2021 | 4849 | 0.16 | Why? |
| Mice | 10 | 2021 | 21357 | 0.15 | Why? |
| Flavivirus | 1 | 2017 | 182 | 0.15 | Why? |
| Antibody Affinity | 1 | 2020 | 1078 | 0.15 | Why? |
| Vaccines, Subunit | 1 | 2021 | 1088 | 0.14 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.14 | Why? |
| Blotting, Western | 1 | 2017 | 863 | 0.14 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2021 | 676 | 0.14 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.14 | Why? |
| Vaccines, DNA | 1 | 2021 | 871 | 0.14 | Why? |
| Chemokines | 1 | 2020 | 1095 | 0.13 | Why? |
| T-Lymphocytes | 3 | 2021 | 6670 | 0.13 | Why? |
| Macaca mulatta | 5 | 2021 | 3716 | 0.13 | Why? |
| Genetic Vectors | 1 | 2021 | 1600 | 0.13 | Why? |
| Polysaccharides | 1 | 2021 | 854 | 0.13 | Why? |
| Bronchi | 1 | 2020 | 1048 | 0.13 | Why? |
| Furin | 1 | 2021 | 1054 | 0.13 | Why? |
| Immunodominant Epitopes | 1 | 2018 | 813 | 0.13 | Why? |
| Dogs | 1 | 2020 | 2529 | 0.12 | Why? |
| Receptors, Immunologic | 1 | 2017 | 555 | 0.12 | Why? |
| Receptors, Antigen, T-Cell | 1 | 2018 | 760 | 0.12 | Why? |
| Systems Biology | 1 | 2015 | 320 | 0.12 | Why? |
| Virion | 1 | 2020 | 1444 | 0.12 | Why? |
| Hematopoietic Stem Cells | 1 | 2015 | 321 | 0.12 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.11 | Why? |
| Gene Expression | 2 | 2021 | 3332 | 0.11 | Why? |
| Humans | 35 | 2021 | 930598 | 0.11 | Why? |
| Binding Sites | 2 | 2021 | 6201 | 0.11 | Why? |
| Signal Transduction | 3 | 2017 | 7207 | 0.11 | Why? |
| Viral Vaccines | 3 | 2021 | 7560 | 0.11 | Why? |
| Antibody Formation | 2 | 2021 | 4038 | 0.11 | Why? |
| Virus Internalization | 2 | 2020 | 7921 | 0.11 | Why? |
| Disease Models, Animal | 5 | 2021 | 10998 | 0.10 | Why? |
| Nucleocapsid Proteins | 2 | 2021 | 3120 | 0.10 | Why? |
| RNA | 1 | 2017 | 1278 | 0.10 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.10 | Why? |
| Mice, Inbred C57BL | 2 | 2018 | 5542 | 0.09 | Why? |
| Immunization, Secondary | 3 | 2021 | 1649 | 0.09 | Why? |
| Pregnancy | 3 | 2020 | 23879 | 0.09 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 1645 | 0.09 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.09 | Why? |
| RNA, Double-Stranded | 1 | 2009 | 226 | 0.09 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.09 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.09 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.08 | Why? |
| Interferon Regulatory Factor-3 | 1 | 2009 | 379 | 0.08 | Why? |
| Administration, Intranasal | 2 | 2021 | 1132 | 0.08 | Why? |
| Viral Load | 4 | 2021 | 15850 | 0.08 | Why? |
| Hemagglutinins, Viral | 1 | 2006 | 176 | 0.08 | Why? |
| Mesocricetus | 2 | 2021 | 1847 | 0.08 | Why? |
| Immunoglobulin G | 5 | 2021 | 21571 | 0.07 | Why? |
| Fibroblasts | 1 | 2009 | 839 | 0.07 | Why? |
| Hepacivirus | 1 | 2015 | 1509 | 0.07 | Why? |
| Protein Binding | 4 | 2021 | 11430 | 0.07 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.07 | Why? |
| Protein Domains | 3 | 2021 | 6563 | 0.07 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.06 | Why? |
| Female | 16 | 2021 | 380317 | 0.06 | Why? |
| Interferon-beta | 1 | 2009 | 979 | 0.06 | Why? |
| Cricetinae | 2 | 2021 | 3344 | 0.06 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.06 | Why? |
| HEK293 Cells | 3 | 2021 | 8394 | 0.06 | Why? |
| Lung | 6 | 2021 | 31049 | 0.06 | Why? |
| Virus Replication | 2 | 2021 | 14331 | 0.06 | Why? |
| Betacoronavirus | 3 | 2021 | 204454 | 0.06 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.06 | Why? |
| Mannose | 1 | 2021 | 68 | 0.06 | Why? |
| Gene Order | 1 | 2021 | 144 | 0.05 | Why? |
| Hydroxyurea | 1 | 2021 | 87 | 0.05 | Why? |
| Oligodeoxyribonucleotides | 1 | 2021 | 206 | 0.05 | Why? |
| Half-Life | 1 | 2021 | 298 | 0.05 | Why? |
| Squalene | 1 | 2021 | 196 | 0.05 | Why? |
| Liver | 1 | 2015 | 4007 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 6653 | 0.05 | Why? |
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 283 | 0.05 | Why? |
| Antibodies, Blocking | 1 | 2020 | 174 | 0.05 | Why? |
| N-Acetylneuraminic Acid | 1 | 2021 | 198 | 0.05 | Why? |
| Antigen-Antibody Reactions | 1 | 2021 | 616 | 0.05 | Why? |
| Mutant Proteins | 1 | 2021 | 328 | 0.05 | Why? |
| Clinical Trials, Phase I as Topic | 1 | 2021 | 242 | 0.05 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2021 | 8843 | 0.05 | Why? |
| Macaca | 1 | 2021 | 388 | 0.05 | Why? |
| Immunoglobulin Isotypes | 1 | 2021 | 308 | 0.05 | Why? |
| Protein Array Analysis | 1 | 2021 | 387 | 0.05 | Why? |
| Male | 15 | 2021 | 367725 | 0.05 | Why? |
| Adolescent | 7 | 2021 | 86841 | 0.05 | Why? |
| Blood Sedimentation | 1 | 2020 | 508 | 0.05 | Why? |
| Young Adult | 7 | 2021 | 93724 | 0.04 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2021 | 801 | 0.04 | Why? |
| Phosphorylation | 1 | 2021 | 1060 | 0.04 | Why? |
| Protein Subunits | 1 | 2020 | 755 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2020 | 907 | 0.04 | Why? |
| Membrane Glycoproteins | 1 | 2006 | 2273 | 0.04 | Why? |
| Animals, Newborn | 1 | 2018 | 350 | 0.04 | Why? |
| Proteolysis | 1 | 2021 | 751 | 0.04 | Why? |
| Macrophages, Alveolar | 1 | 2021 | 668 | 0.04 | Why? |
| Cattle | 1 | 2021 | 1336 | 0.04 | Why? |
| Post-Exposure Prophylaxis | 1 | 2021 | 472 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.04 | Why? |
| Models, Molecular | 2 | 2021 | 7616 | 0.04 | Why? |
| CD4-Positive T-Lymphocytes | 2 | 2021 | 4545 | 0.04 | Why? |
| Immunophenotyping | 1 | 2021 | 1290 | 0.04 | Why? |
| CD146 Antigen | 1 | 2015 | 19 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Down Syndrome | 1 | 2020 | 397 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Vaccination | 4 | 2021 | 19050 | 0.04 | Why? |
| Transcription, Genetic | 1 | 2021 | 1326 | 0.04 | Why? |
| Mice, Inbred BALB C | 2 | 2021 | 5814 | 0.04 | Why? |
| Serine Endopeptidases | 2 | 2021 | 4606 | 0.04 | Why? |
| Administration, Inhalation | 1 | 2021 | 1647 | 0.04 | Why? |
| Antigens, CD34 | 1 | 2015 | 125 | 0.04 | Why? |
| Th1 Cells | 1 | 2020 | 1228 | 0.03 | Why? |
| Hematopoiesis | 1 | 2015 | 168 | 0.03 | Why? |
| Viral Envelope Proteins | 1 | 2006 | 3539 | 0.03 | Why? |
| Cell Lineage | 1 | 2015 | 241 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2020 | 1706 | 0.03 | Why? |
| Adenosine Monophosphate | 2 | 2021 | 5652 | 0.03 | Why? |
| Alanine | 2 | 2021 | 5687 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2020 | 2134 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2021 | 1387 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2020 | 2689 | 0.03 | Why? |
| Regression Analysis | 1 | 2020 | 2484 | 0.03 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2020 | 1267 | 0.03 | Why? |
| Aged | 7 | 2021 | 215776 | 0.03 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2021 | 1138 | 0.03 | Why? |
| Adult | 7 | 2021 | 244371 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| Single-Cell Analysis | 1 | 2021 | 2450 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.03 | Why? |
| Autoantibodies | 1 | 2021 | 2094 | 0.02 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.02 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2021 | 6049 | 0.02 | Why? |
| DNA Virus Infections | 1 | 2009 | 88 | 0.02 | Why? |
| Antimalarials | 1 | 2021 | 2505 | 0.02 | Why? |
| Epitopes | 1 | 2021 | 4113 | 0.02 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.02 | Why? |
| Transcriptome | 1 | 2021 | 3466 | 0.02 | Why? |
| RNA Virus Infections | 1 | 2009 | 231 | 0.02 | Why? |
| Infant | 2 | 2020 | 30274 | 0.02 | Why? |
| Child | 3 | 2021 | 70012 | 0.02 | Why? |
| Lung Diseases | 1 | 2021 | 2361 | 0.02 | Why? |
| Encephalitis Virus, Venezuelan Equine | 1 | 2006 | 71 | 0.02 | Why? |
| Promoter Regions, Genetic | 1 | 2009 | 823 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Hepatitis C, Chronic | 1 | 2015 | 973 | 0.02 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2015 | 907 | 0.02 | Why? |
| Pediatrics | 1 | 2021 | 2969 | 0.02 | Why? |
| Antineoplastic Agents | 1 | 2021 | 3550 | 0.02 | Why? |
| Replicon | 1 | 2006 | 232 | 0.02 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.02 | Why? |
| India | 1 | 2021 | 11875 | 0.02 | Why? |
| SARS Virus | 1 | 2006 | 13021 | 0.02 | Why? |
| Disease Management | 1 | 2021 | 6841 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.01 | Why? |
| Molecular Sequence Data | 1 | 2006 | 3198 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.01 | Why? |
| Gene Expression Regulation | 1 | 2009 | 4020 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.01 | Why? |
| Viruses | 1 | 2009 | 2238 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2021 | 14232 | 0.01 | Why? |
| Zoonoses | 1 | 2006 | 3034 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 7868 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| Aging | 1 | 2006 | 3581 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Treatment Outcome | 1 | 2006 | 51732 | 0.00 | Why? |
| Disease Outbreaks | 1 | 2006 | 27595 | 0.00 | Why? |